IBRX Stock-Based Compensation
Immunitybio Inc · Stock-Based Compensation
IBRX Stock-Based Compensation
Latest reported$34.31Mperiod ending
IBRX TTM Stock-Based Comp ($789.00K → $34.31M)
TTM stock-based compensation
High-resolution chart · PNG
IBRX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 34,311,000 | |
| 35,441,000 | |
| 36,809,000 | |
| 37,101,000 | |
| 35,712,000 | |
| 35,703,000 | |
| 34,432,000 | |
| 38,168,000 | |
| 45,128,000 | |
| 46,551,000 | |
| 49,163,000 | |
| 45,739,000 | |
| 41,920,000 | |
| 41,033,000 | |
| 40,179,000 | |
| 41,009,000 | |
| 44,219,000 | |
| 51,907,000 | |
| 57,181,000 | |
| 47,672,000 | |
| 34,546,000 | |
| 17,005,000 | |
| 2,187,000 | |
| 1,516,000 | |
| 1,079,000 | |
| 1,279,000 | |
| 2,150,000 | |
| 3,557,000 | |
| 7,248,000 | |
| 15,660,000 | |
| 23,382,000 | |
| 30,859,000 | |
| 35,605,000 | |
| 36,052,000 | |
| 36,997,000 | |
| 39,379,000 | |
| 49,334,000 | |
| 63,335,000 | |
| 73,852,000 | |
| 133,140,000 | |
| 150,574,000 | |
| 207,233,000 | |
| 211,221,000 | |
| 141,260,000 | |
| 105,186,000 | |
| 25,177,000 | |
| 789,000 |